InsiderClue
Insiders · Profile

Evans John M.

CEO at Beam Therapeutics. Filing since 30 Dec 2020. CIK 0001786304

Company
Date
Role
Action
Shares
Amount
Of holding
BEAM Beam Therapeutics Inc.
30 Jun 2026
CEO
Sold on a plan
25,000
$857.69K
2.3%
BEAM Beam Therapeutics Inc.
29 Jun 2026
CEO
Sold on a plan
25,000
$887.35K
2.3%
BEAM Beam Therapeutics Inc.
1 Apr 2026
CEO
Sold on a plan
30,078
$739.32K
2.8%
BEAM Beam Therapeutics Inc.
31 Mar 2026
CEO
Sold on a plan
25,000
$569.09K
2.5%
BEAM Beam Therapeutics Inc.
30 Mar 2026
CEO
Sold on a plan
25,000
$559.23K
2.5%
BEAM Beam Therapeutics Inc.
30 Jan 2026
CEO
Sold on a plan
25,000
$708.95K
2.5%
BEAM Beam Therapeutics Inc.
29 Jan 2026
CEO
Sold on a plan
25,000
$734.58K
2.5%
BEAM Beam Therapeutics Inc.
2 Oct 2025
CEO
Sold on a plan
25,000
$615.67K
2.5%
BEAM Beam Therapeutics Inc.
1 Oct 2025
CEO
Sold on a plan
25,000
$612.66K
2.5%
BEAM Beam Therapeutics Inc.
1 Apr 2025
CEO
Sold on a plan
30,663
$562.68K
3.0%
BEAM Beam Therapeutics Inc.
30 Jan 2025
CEO
Sold on a plan
30,000
$802.48K
3.2%
BEAM Beam Therapeutics Inc.
30 Sep 2024
CEO
Sold on a plan
60,000
$1.48M
6.0%
BEAM Beam Therapeutics Inc.
27 Jun 2024
CEO
Sold on a plan
60,000
$1.47M
5.7%
BEAM Beam Therapeutics Inc.
1 Apr 2024
CEO
Sold on a plan
18,102
$581.62K
1.7%
BEAM Beam Therapeutics Inc.
28 Mar 2024
CEO
Sold on a plan
60,000
$2.03M
5.7%
BEAM Beam Therapeutics Inc.
31 Jan 2024
CEO
Sold on a plan
60,000
$1.52M
5.4%
BEAM Beam Therapeutics Inc.
4 Apr 2023
CEO
Sold on a plan
6,493
$188.90K
0.6%
BEAM Beam Therapeutics Inc.
3 Apr 2023
CEO
Sold on a plan
5,161
$156.43K
0.5%
BEAM Beam Therapeutics Inc.
31 Oct 2022
CEO
Sold, plan not stated
30,000
$1.39M
2.8%
BEAM Beam Therapeutics Inc.
31 Oct 2022
CEO
Sold, plan not stated
20,000
$927.20K
16.3%
BEAM Beam Therapeutics Inc.
28 Jul 2022
CEO
Sold, plan not stated
30,000
$1.97M
2.7%
BEAM Beam Therapeutics Inc.
28 Jul 2022
CEO
Sold, plan not stated
20,000
$1.32M
14.0%
BEAM Beam Therapeutics Inc.
28 Apr 2022
CEO
Sold, plan not stated
30,000
$1.14M
2.6%
BEAM Beam Therapeutics Inc.
28 Apr 2022
CEO
Sold, plan not stated
20,000
$759.60K
12.3%
BEAM Beam Therapeutics Inc.
31 Mar 2022
CEO
Sold, plan not stated
6,261
$370.09K
0.6%
BEAM Beam Therapeutics Inc.
6 Oct 2021
CEO
Sold, plan not stated
27,700
$2.32M
2.6%
BEAM Beam Therapeutics Inc.
6 Oct 2021
CEO
Sold, plan not stated
20,000
$1.68M
9.9%
BEAM Beam Therapeutics Inc.
19 Aug 2021
CEO
Sold, plan not stated
20,000
$1.99M
9.0%
BEAM Beam Therapeutics Inc.
7 Jul 2021
CEO
Sold, plan not stated
25,000
$2.70M
2.4%
BEAM Beam Therapeutics Inc.
21 Apr 2021
CEO
Sold, plan not stated
25,000
$1.76M
2.4%
BEAM Beam Therapeutics Inc.
30 Dec 2020
CEO
Sold, plan not stated
22,300
$1.89M
2.2%
31 decisions on file.